Anna Torrent
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Erratum for Laporte-Amargos et al., "Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia".
Journal: Antimicrobial agents and chemotherapy
Published: July 15, 2026
Timing of Allogeneic Hematopoietic Cell Transplantation After Inotuzumab Ozogamicin Influences Sinusoidal Obstruction Syndrome and Survival in Relapsed/Refractory B-ALL.
Journal: Transplantation and cellular therapy
Published: June 15, 2026
Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALL.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 08, 2026
Lymphoblastic lymphoma in adults: diagnosis, prognosis and treatment.
Journal: Medicina clinica
Published: May 07, 2026
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.
Journal: Bone marrow transplantation
Published: January 21, 2026
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
Journal: Transplantation and cellular therapy
Published: January 08, 2026
Systematic echocardiography in patients with hematological malignancies and Gram-positive bacteremia, is it really needed?
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 15, 2025
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia.
Journal: Antimicrobial agents and chemotherapy
Published: November 25, 2025
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: October 06, 2025
EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study.
Journal: Transplantation and cellular therapy
Published: August 07, 2025
Last Updated: 09/26/2026